Clinical characteristics of infections due to Staphylococcus lugdunensis compared to other staphylococcal infections.
7 affiliations
- 1Department of Internal Medicine, University of Balamand, Beirut, Lebanon.
- 2Department of Internal Medicine, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
- 3Department of Internal Medicine, American University of Beirut, PO Box 11-0236/11D, Cairo Street , Riad El Solh, Beirut, 1107 2020, Lebanon.
- 4Department of Pediatrics, Duke Children Hospital and Health Care, Durham, NC, USA.
- 5Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
- 6Department of Radiology, American University of Beirut, Beirut, Lebanon.
- 7Department of Internal Medicine, American University of Beirut, PO Box 11-0236/11D, Cairo Street , Riad El Solh, Beirut, 1107 2020, Lebanon. [email protected].
Abstract
Background
Staphylococcus lugdunensis is a coagulase-negative staphylococcal species with virulence characteristics resembling those of Staphylococcus aureus. Despite its increasing recognition as a clinically significant pathogen, data comparing its clinical outcomes with other staphylococcal infections remain limited. This study aimed to compare the clinical characteristics, outcomes, and factors associated with unfavorable clinical outcomes among patients with S. lugdunensis, S. aureus, and Staphylococcus epidermidis infections.Methods
We conducted a retrospective cohort study at the American University of Beirut Medical Center between January 2019 and December 2023. Adult patients with S. lugdunensis infections were identified and matched by site of infection to patients with S. aureus and S. epidermidis infections. Demographic, clinical, microbiological, treatment, and outcome data were collected. Bivariable analyses and multivariable logistic regression were performed to identify factors independently associated with unfavorable clinical outcome, defined as a composite of in-hospital mortality and major infection-related complications.Results
A total of 301 patients were included: 101 with S. lugdunensis, 103 with S. aureus, and 97 with S. epidermidis infections. Skin and soft tissue infections were the most common presentation of S. lugdunensis (72%), followed by urinary tract infections (16%), bacteremia (8%), and respiratory infections (4%). Compared with S. aureus, S. lugdunensis infections were associated with lower rates of persistent bacteremia (0% vs. 4.9%, p = 0.025) and higher rates of acute renal failure (8.9% vs. 1.9%, p = 0.028). No significant outcome differences were observed between S. lugdunensis and S. epidermidis infections. Overall in-hospital mortality rates were 7.9%, 5.8%, and 7.2% for S. lugdunensis, S. aureus, and S. epidermidis, respectively. In multivariable analysis, S. aureus infection was associated with lower odds of unfavorable clinical outcome than S. lugdunensis (aOR 0.31, 95% CI 0.13-0.75), whereas no significant difference was observed between S. lugdunensis and S. epidermidis. Diabetes mellitus (aOR 2.71, 95% CI 1.27-5.82) and hospitalization within the previous 30 days (aOR 1.97, 95% CI 1.26-3.06) were independently associated with unfavorable clinical outcome.Conclusions
S. lugdunensis demonstrates clinical characteristics and outcomes overlapping those of S. aureus and S. epidermidis. Prompt recognition and appropriate management remain essential to optimize clinical outcomes.
Related
- Characteristics of Staphylococcus lugdunensis isolated from humans and animals
- Chlorhexidine MIC distribution, efflux pump gene profiles, and genotypic characteristics among clinical methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates
- Perinatal maternal infections among mothers attending an urban Ghanaian hospital: clinical characteristics and predictors of infections
- Clinical characteristics, pathogen detection, and severity markers among children with acute respiratory infections during the COVID-19 restriction period: a retrospective hospital-based study
- A fluorogenic biotracer for reliable detection of staphylococcal beta-lactamase: towards improved precision therapy in severe MSSA infections
BibTeX
@article{harb2026clinical,
title = {{Clinical characteristics of infections due to Staphylococcus lugdunensis compared to other staphylococcal infections.}},
author = {Souad Bou Harb and Reem Mansour and Lea Al Zoghby and Alicia Khazzeka and Ayah Matar and Youssef Zoughaib and Zeina A Kanafani},
journal = {BMC infectious diseases},
year = {2026},
month = jul,
doi = {10.1186/s12879-026-14068-x},
url = {https://europepmc.org/article/MED/42928117},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Clinical characteristics of infections due to Staphylococcus lugdunensis compared to other staphylococcal infections.
AU - Souad Bou Harb
AU - Reem Mansour
AU - Lea Al Zoghby
AU - Alicia Khazzeka
AU - Ayah Matar
AU - Youssef Zoughaib
AU - Zeina A Kanafani
PY - 2026
DA - 2026/07/28
JO - BMC infectious diseases
DO - 10.1186/s12879-026-14068-x
UR - https://europepmc.org/article/MED/42928117
AB - Background Staphylococcus lugdunensis is a coagulase-negative staphylococcal species with virulence characteristics resembling those of Staphylococcus aureus. Despite its increasing recognition as a clinically significant pathogen, data comparing its clinical outcomes with other staphylococcal infections remain limited. This study aimed to compare the clinical characteristics, outcomes, and factors associated with unfavorable clinical outcomes among patients with S. lugdunensis, S. aureus, and Staphylococcus epidermidis infections.Methods We conducted a retrospective cohort study at the American University of Beirut Medical Center between January 2019 and December 2023. Adult patients with S. lugdunensis infections were identified and matched by site of infection to patients with S. aureus and S. epidermidis infections. Demographic, clinical, microbiological, treatment, and outcome data were collected. Bivariable analyses and multivariable logistic regression were performed to identify factors independently associated with unfavorable clinical outcome, defined as a composite of in-hospital mortality and major infection-related complications.Results A total of 301 patients were included: 101 with S. lugdunensis, 103 with S. aureus, and 97 with S. epidermidis infections. Skin and soft tissue infections were the most common presentation of S. lugdunensis (72%), followed by urinary tract infections (16%), bacteremia (8%), and respiratory infections (4%). Compared with S. aureus, S. lugdunensis infections were associated with lower rates of persistent bacteremia (0% vs. 4.9%, p = 0.025) and higher rates of acute renal failure (8.9% vs. 1.9%, p = 0.028). No significant outcome differences were observed between S. lugdunensis and S. epidermidis infections. Overall in-hospital mortality rates were 7.9%, 5.8%, and 7.2% for S. lugdunensis, S. aureus, and S. epidermidis, respectively. In multivariable analysis, S. aureus infection was associated with lower odds of unfavorable clinical outcome than S. lugdunensis (aOR 0.31, 95% CI 0.13-0.75), whereas no significant difference was observed between S. lugdunensis and S. epidermidis. Diabetes mellitus (aOR 2.71, 95% CI 1.27-5.82) and hospitalization within the previous 30 days (aOR 1.97, 95% CI 1.26-3.06) were independently associated with unfavorable clinical outcome.Conclusions S. lugdunensis demonstrates clinical characteristics and outcomes overlapping those of S. aureus and S. epidermidis. Prompt recognition and appropriate management remain essential to optimize clinical outcomes.
SN - 1471-2334
ER -